BetterScholar BetterScholar

R. Sugimoto

Annals of Oncology, Liver international, Journal of Hepatology, The Lancet, Clinical and Experimental Pharmacology and Physiology, Hepatology Show more
10
Role
Title
Level Year L/R
🐜 Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
201 auth. R. Kate Kelley, M. Ueno, C. Yoo, Richard S Finn, J. Furuse, Z. Ren, T. Yau, H. Klümpen, Stephen L Chan, M. Ozaka, C. Verslype, M. Bouattour, Joon-Oh Park, O. Barajas, U. Pelzer, ... J. Valle, Li Yu, U. Malhotra, A. Siegel, J. Edeline, A. Vogel, M. Akce, Inmaculada Ales Diaz, G. Alves, Sumitra Anand, Ç. Arslan, J. Asselah, E. Assenat, F. Aubin, L. Bai, Y. Bai, Susan Bates, S. Begbie, I. Ben-Aharon, Nina Beri, M. Berres, J. Blanc, I. Borbath, R. Bordonaro, G. Brandi, Adam H. Burgoyne, Kritiya Butthongkomvong, M. Camandaroba, Ke Cao, M. Carballido, Stephan Lam Chan, Jen‐Shi Chen, Ming-Huang Chen, Xiaoming Chen, A. Cheng, T. Chiu, Hye Jin Choi, H. Chon, J. Collignon, A. C. Gracián, Sarah Davis, Ricardo Saraiva de Carvalho, D. J. Groot, A. Demols, J. Vos, M. Diab, J. Easaw, M. Eatock, Rawad Elias, F. Eskens, A. Falcone, P. Fernández, Richard S Finn, F. Franke, M. Furukawa, O. Gbolahan, K. Geboes, Keri-Lee Geneser, Zhimin Geng, R. Geva, R. Gillmore, T. Goetze, Hongfeng Gou, J. Grasselli, S. Gu, M. Gumus, N. H. Mohammad, C. Hao, H. Harputluoglu, H. Hatoum, V. Heinemann, W.K. Ho, C. Hsu, A. Hubert, J. Hwang, M. Inanc, S. Iseas, Vaishnavi Jeyasingam, P. Fonseca, W. Joubert, J. Juengsamarn, D. Kaen, Masashi Kanai, Stefan Kasper-Virchow, G. Kazemi, F. Kelleher, R. Kate Kelley, Jin Won Kim, Jong Gwang Kim, A. Abrahao, H. Klumpen, M. Kochenderfer, F. Kose, Ho-Ching Lam, Choong-kun Lee, Hyun Woo Lee, Margaret Lee, Myung Ah Lee, W. Lee, S. Sourd, Dongliang Li, Wei Li, Houjie Liang, T. Liang, Chun Sen Lim, B. Lingerfelt, Charles A. Lopez, J. Low, T. M. Mercadé, D. Malka, Y. Mao, G. Masi, S. McCune, R. McDermott, E. Mcwhirter, G. Mendez, M. Milella, Nobumasa Mizuno, T. Mizutani, C. Moniz, Luisa Morales, A. J. M. Martín, B. Nervi, N. Ngamphaiboon, S. Oh, B. Oksuzoglu, D. Outlaw, M. Ozguroglu, O. Ozyılkan, C. Painemal, Yueyin Pan, Chuang Peng, C. Pétorin, D. Pezet, D. Power, S. Qin, A. Roohullah, Hyewon Ryu, P. Salman, Mitsuhito Sasaki, R. Sasidharan, T. Satoh, K. Schulze, M. Scott-Brown, Rubén Segovia, Thomas Seufferlein, Salvatore Siena, I. Sinapi, C. Smolenschi, T. Song, A. Sookprasert, N. Soparattanapaisarn, N. Starling, S. Stein, S. Stemmer, Haichuan Su, R. Sugimoto, T. Suksombooncharoen, V. Tam, Ai Lian Tan, C. Tan, S. Tanasanvimon, G. Tonini, G. Tortora, A. Tsuji, Rodrigo Uribe, M. Venerito, H. Mata, A. Victorino, J. Wade, D. Waldschmidt, Lulu Wang, Wan Zamaniah Wan Isahk, Harpeet Wasan, R. Weschenfelder, Chun-yin Louisa Wong, Y. F. Wong, Ş. Yalçın, P. Weber, Xuezhong Yang, H. Yasui, O. Yazıcı, C. Yen, J. Ying, Wenchang Yu, Haitao Zhao 		8 2023
8
🐜
🐜 Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: The FUGA-BT (JCOG1113) Randomized Phase III Clinical Trial.
37 auth. C. Morizane, T. Okusaka, J. Mizusawa, H. Katayama, M. Ueno, Masataka Ikeda, M. Ozaka, N. Okano, K. Sugimori, A. Fukutomi, H. Hara, N. Mizuno, H. Yanagimoto, K. Wada, K. Tobimatsu, ... K. Yane, S. Nakamori, H. Yamaguchi, A. Asagi, S. Yukisawa, Y. Kojima, K. Kawabe, Y. Kawamoto, R. Sugimoto, T. Iwai, Kenji Nakamura, H. Miyakawa, T. Yamashita, A. Hosokawa, T. Ioka, N. Kato, K. Shioji, K. Shimizu, T. Nakagohri, K. Kamata, H. Ishii, J. Furuse 		7 2019
7
🐜
🐜 Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
18 auth. M. Ikeda, S. Shimizu, Tosiya Sato, M. Morimoto, Y. Kojima, Y. Inaba, A. Hagihara, M. Kudo, S. Nakamori, S. Kaneko, ... R. Sugimoto, T. Tahara, T. Ohmura, K. Yasui, Keiko Sato, H. Ishii, J. Furuse, T. Okusaka 		7 2016
7
🐜
🐜 Activation of retinoic X receptor and peroxisome proliferator–activated receptor‐γ inhibits nitric oxide and tumor necrosis factor‐α production in rat Kupffer cells
8 auth. K. Uchimura, M. Nakamuta, M. Enjoji, T. Irie, R. Sugimoto, T. Muta, ... H. Iwamoto, H. Nawata 		6 2001
6
🐜
🦁 High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen‐activated protein kinase
10 auth. R. Sugimoto, M. Enjoji, M. Kohjima, S. Tsuruta, M. Fukushima, M. Iwao, ... T. Sonta, K. Kotoh, T. Inoguchi, M. Nakamuta 		6 2005
6
🦁
🐬 A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth.
H. Iwamoto, M. Nakamuta, S. Tada, R. Sugimoto, M. Enjoji, H. Nawata 		6 2000
6
🐬
🐜 A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats.
7 auth. S. Tada, H. Iwamoto, M. Nakamuta, R. Sugimoto, M. Enjoji, Y. Nakashima, ... H. Nawata 		6 2001
6
🐜
🦁 Effect of IL‐4 and IL‐13 on collagen production in cultured LI90 human hepatic stellate cells
11 auth. R. Sugimoto, M. Enjoji, M. Nakamuta, S. Ohta, M. Kohjima, M. Fukushima, ... M. Kuniyoshi, E. Arimura, S. Morizono, K. Kotoh, H. Nawata 		6 2005
6
🦁
🐜 Pirfenidone Inhibits Dimethylnitrosamine‐Induced Hepatic Fibrosis In Rats
8 auth. S. Tada, M. Nakamuta, M. Enjoji, R. Sugimoto, H. Iwamoto, Masaki Kato, ... Yutaka Nakashima, H. Nawata 		6 2001
6
🐜
🐜 Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
8 auth. K. Uchimura, M. Nakamuta, M. Enjoji, T. Irie, R. Sugimoto, T. Muta, ... H. Iwamoto, H. Nawata 		5 2001
5
🐜